Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: dermal
Type of information:
experimental study
Adequacy of study:
supporting study
Study period:
Dec 2000
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: well reported GLP Guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2001
Report date:
2001

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 402 (Acute Dermal Toxicity)
Deviations:
yes
Remarks:
3 instead of 5 animals/sex used according to acute-toxic-class-method (OECD 423)
GLP compliance:
yes (incl. QA statement)
Test type:
standard acute method
Limit test:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
17β-hydroxy-17-(3-hydroxypropyl)androst-4-ene-4-one
EC Number:
259-701-7
EC Name:
17β-hydroxy-17-(3-hydroxypropyl)androst-4-ene-4-one
Cas Number:
55542-27-3
Molecular formula:
C22H34O3
IUPAC Name:
17 beta-Hydroxy-17 alpha-(3-hydroxypropyl)-4-androsten-3-one
Details on test material:
- Name of test material (as cited in study report): ZK 57797
- Batch No: 59012052, white powder
- Purity: approx. 91.2% (DC)

Test animals

Species:
rat
Strain:
Wistar
Sex:
male/female

Administration / exposure

Type of coverage:
occlusive
Vehicle:
other: 0.5% (m/v) solution of Tylose MH 1000 in distilled water
Duration of exposure:
24 hours
Doses:
2000 mg/kg bw
No. of animals per sex per dose:
3
Control animals:
no

Results and discussion

Effect levels
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 2 000 mg/kg bw
Based on:
test mat.

Any other information on results incl. tables

No mortalities occurred. No clinical signs, changes in body weight gain or pathological findings were observed. Moreover, no compound-related local findings were observed. None of the animals showed alterations of the skin on the administration area.

Applicant's summary and conclusion

Executive summary:

The single dermal administration of the test substance (ZK 57797) to male and female rats at a dose of 2000 mg/kg was tolerated without any mortality, clinical signs, body weight changes or pathological findings.

The acute dermal toxicity of Hydroxypropyltesto in rats is therefore above 2000 mg/kg body weight.

Moreover, no compound-related local findings were observed. None of the animals showed alterations of the skin (edema and/or erytthema) on the administration area.